Сунитиниб Крка

Сунитиниб Крка is an oral medication used for targeted therapy in oncology. It belongs to the tyrosine kinase inhibitor class, supporting treatment of certain cancers. This EU-manufactured product offers a systemic approach to disease management.

Sunitinib is primarily used to treat advanced kidney cancer and gastrointestinal stromal tumors (GIST). It may also be prescribed for pancreatic neuroendocrine tumors in specific cases. The medication works by slowing or stopping the growth of cancer cells. Patients often ask, 'What is sunitinib used for?' to understand its role in cancer care.

Sunitinib helps reduce tumor progression by interfering with signals that promote cancer cell growth. Many patients notice stabilization in their condition over time. It is not a cure but can extend periods of disease control. Common effects include fatigue and digestive changes during therapy.

Keep sunitinib in a cool, dry place away from direct sunlight. Store it securely, out of reach of children and pets. Regular medical check-ups are advised to monitor response and side effects. Report any unusual symptoms to a healthcare provider promptly.

Sunitinib may interact with other medications, including certain antibiotics and antifungals. Grapefruit products can affect how the drug is processed in the body. Always inform your doctor about all prescription and over-the-counter drugs you are taking. Alcohol use should be discussed with a healthcare professional.